Weight variability at pediatric intensive care unit admission and adverse outcomes in critically ill children

Jae Hwa Jung1, Yoon Hee Kim2, Min Jung Kim3

  • 1Department of Pediatrics, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Acute and Critical Care
|December 11, 2025
PubMed

Insights

Acute body weight variability in critically ill children is linked to worse outcomes. Higher weight variability at pediatric intensive care unit admission predicts increased mortality and fewer ventilator-free days.

Area of Science:

  • Pediatric critical care medicine
  • Clinical outcomes research
  • Patient monitoring

Background:

  • Body weight fluctuates in critically ill children due to fluid shifts, nutrition, illness type, and comorbidities.
  • Acute body weight variability (WV) is a potential indicator of clinical status.
  • Understanding WV's impact is crucial for pediatric intensive care unit (PICU) management.

Purpose of the Study:

  • To investigate the association between acute body weight variability (WV) and clinical outcomes in critically ill pediatric patients.
  • To determine if WV can enhance existing mortality prediction models.

Main Methods:

  • Retrospective analysis of 926 pediatric patients (1 month to 18 years) admitted to a PICU.
  • WV defined as percentage difference between admission weight and usual body weight.
  • Association of WV with PICU mortality and ventilator-free days (VFDs) assessed.

Main Results:

  • Median WV was significantly higher in non-survivors (8.7%) versus survivors (0.0%).
  • Increased WV independently predicted higher mortality (HR, 1.102) and fewer VFDs (OR, 0.599).
  • WV combined with the Pediatric Index of Mortality 3 score improved mortality prediction (AUC, 0.888).

Conclusions:

  • Higher body weight variability at PICU admission is independently associated with adverse outcomes.
  • WV may serve as a valuable tool to complement existing pediatric critical care mortality prediction models.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
240
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
231
Variability: Analysis01:11

Variability: Analysis

Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
421
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
2.8K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
981